Semaglutide does not target muscle tissue
Tirzepatide versus semaglutide once weekly in patients with Type 2 diabetes, The New England Journal of Medicine (2021) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network (2022) Tirzepatide once weekly for the treatment of obesity, The New England Journal of Medicine (2022) Mounjaro, tirzepatide injection, solution, DailyMed (2024) Ozempic semaglutide injection, solution, DailyMed (2023) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial, Lancet (2021) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, U.S
If even these alternatives dont strike your fancy, you could forgo supplements altogether and work on modifying your diet
However, if they become more severe or dont go away, talk with your doctor or pharmacist